...BRCA2, before the start of treatment. This could alter treatment decisions; for instance, more women might opt for maste...
The cloning of the breast cancer susceptibility genes BRCA1 and BRCA2 nearly two decades ago helped set in motion an ava...
Germline mutations in BRCA1 and BRCA2 predispose to common human malignancies, most notably tumors of the breast and ova...
...BRCA2 (BRCA1/2) mutation were four times more likely to develop breast cancer compared to women in the general populatio...
...BRCA2 in Sudanese breast cancer patients, the methylation status of six tumor suppressor genes was investigated using me...
Identification of the 10% to 15% of patients with ovarian cancer who have germline BRCA1 or BRCA2 mutations is important...
...BRCA2-binding partner protein that represses the DNA repair function of BRCA2 in non-hereditary breast cancer. Although ...
...BRCA2 tumor suppressors to DNA damage foci through multivalent binding of Lys-63-linked polyubiquitin chains. Mutations ...
...BRCA2-mutated and BRCA2-mutated ovarian cancer compared to their normal tissues; BRCA1 repression (BRCA1 mutation or BRC...
...BRCA2 mutations. The patient with the intraductal papillary mucinous neoplasm had Peutz-Jeghers syndrome. All 3 patients...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
